| 摘要 |
The present invention provides a means of treating and preventing bacterial infection through numerous highly-specific bacteriophage strains that combine to fight a target infection. According to the invention, each composition or combined preparation contains classes of multiple bespoke building blocks/elements (specific bacteriophage strains) directed against: (a) the "target" pathogenic bacterial species in a given host tissue, organ or organ system; (b) bacteria which are likely to co- infect and / or colonise the patient in a site-specific manner, which are capable of producing disease (pathogenic) once that target species has been removed, particularly in a healthcare setting; (c) commonly-encountered bacteria likely to be encountered opportunistically throughout the body (in a non-site-specific manner), particularly in a healthcare setting; and (d) clonally-expanded multi-drug-resistant bacteria particularly of the same target species, as in (a) above, and especially those prevalent in a defined area. |
